262 related articles for article (PubMed ID: 30771686)
1. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
Ramirez JL; Gasper WJ; Khetani SA; Zahner GJ; Hills NK; Mitchell PT; Sansbury BE; Conte MS; Spite M; Grenon SM
J Surg Res; 2019 Jun; 238():164-174. PubMed ID: 30771686
[TBL] [Abstract][Full Text] [Related]
2. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
Grenon SM; Owens CD; Nosova EV; Hughes-Fulford M; Alley HF; Chong K; Perez S; Yen PK; Boscardin J; Hellmann J; Spite M; Conte MS
J Am Heart Assoc; 2015 Aug; 4(8):e002034. PubMed ID: 26296857
[TBL] [Abstract][Full Text] [Related]
3. Joint effects of one year of marine omega-3 fatty acid supplementation and participant dietary fish intake upon circulating lipid mediators of inflammation resolution in a randomized controlled trial.
Oakes EG; Vlasakov I; Kotler G; Bubes V; Mora S; Tatituri R; Cook NR; Manson JE; Costenbader KH
Nutrition; 2024 Jul; 123():112413. PubMed ID: 38518540
[TBL] [Abstract][Full Text] [Related]
4. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
5. Synbiotic
Speckmann B; Wagner T; Jordan PM; Werz O; Wilhelm M; Tom Dieck H; Schön C
Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732601
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.
Nosova EV; Chong KC; Alley HF; Harris WS; Boscardin WJ; Conte MS; Owens CD; Grenon SM
J Vasc Surg; 2014 Nov; 60(5):1325-1331. PubMed ID: 24953895
[TBL] [Abstract][Full Text] [Related]
7. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
8. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
9. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
Grenon SM; Owens CD; Alley H; Chong K; Yen PK; Harris W; Hughes-Fulford M; Conte MS
Vasc Med; 2013 Oct; 18(5):263-74. PubMed ID: 24052491
[TBL] [Abstract][Full Text] [Related]
10. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
Mas E; Barden A; Burke V; Beilin LJ; Watts GF; Huang RC; Puddey IB; Irish AB; Mori TA
Clin Nutr; 2016 Apr; 35(2):331-336. PubMed ID: 25908532
[TBL] [Abstract][Full Text] [Related]
12. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
[TBL] [Abstract][Full Text] [Related]
14. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
[TBL] [Abstract][Full Text] [Related]
15. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
16. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease.
Mackay I; Ford I; Thies F; Fielding S; Bachoo P; Brittenden J
Atherosclerosis; 2012 Apr; 221(2):514-20. PubMed ID: 22296885
[TBL] [Abstract][Full Text] [Related]
17. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus.
Wright SA; O'Prey FM; McHenry MT; Leahey WJ; Devine AB; Duffy EM; Johnston DG; Finch MB; Bell AL; McVeigh GE
Ann Rheum Dis; 2008 Jun; 67(6):841-8. PubMed ID: 17875549
[TBL] [Abstract][Full Text] [Related]
18. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.
Grenon SM; Conte MS; Nosova E; Alley H; Chong K; Harris WS; Vittinghoff E; Owens CD
J Vasc Surg; 2013 Nov; 58(5):1283-90. PubMed ID: 23830313
[TBL] [Abstract][Full Text] [Related]
19. Role of specialized pro-resolving mediators on inflammation, cardiometabolic health, disease progression, and quality of life after omega-3 PUFA supplementation and aerobic exercise training in individuals with rheumatoid arthritis: a randomized 16-week, placebo-controlled interventional trial.
Jannas-Vela S; Candia AA; Peñailillo L; Barrios-Troncoso P; Zapata-Urzúa J; Rey-Puente J; Aukema HM; Mutch DM; Valenzuela R; Valladares-Ide D
F1000Res; 2023; 12():942. PubMed ID: 38778807
[No Abstract] [Full Text] [Related]
20. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
